Double maintains 1 strategies that include SRRK - Scholar Rock Holding Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
OCFT | 45.13% | $260.50M | +286.89% | 0.00% |
APD | 38.13% | $62.39B | +1.90% | 2.51% |
EH | 31.34% | $871.86M | +16.68% | 0.00% |
DNA | 31.26% | $496.45M | -50.30% | 0.00% |
AVNW | 30.93% | $279.49M | -25.08% | 0.00% |
GNRC | 27.28% | $7.37B | -7.59% | 0.00% |
NIU | 25.30% | $219.53M | +75.00% | 0.00% |
OC | 22.40% | $11.44B | -23.84% | 1.89% |
PLL | 21.96% | $132.99M | -46.35% | 0.00% |
STG | 21.92% | $29.38M | -15.04% | 0.00% |
BHVN | 21.53% | $1.58B | -54.30% | 0.00% |
CRNC | 21.52% | $364.67M | +182.89% | 0.00% |
LQDA | 21.43% | $1.21B | +8.96% | 0.00% |
NECB | 19.37% | $310.90M | +32.94% | 2.67% |
LSTR | 18.34% | $4.81B | -22.11% | 1.07% |
NOAH | 17.99% | $810.77M | +33.72% | 8.55% |
SMCI | 17.88% | $24.80B | -50.79% | 0.00% |
CSIQ | 17.66% | $739.37M | -35.21% | 0.00% |
CPNG | 17.42% | $51.02B | +31.31% | 0.00% |
CPSH | 17.35% | $37.77M | +52.24% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -16.93% | $30.75M | 0.65% |
LMBS | -16.29% | $5.06B | 0.64% |
IAK | -13.81% | $834.57M | 0.39% |
BTAL | -12.61% | $291.96M | 1.43% |
KIE | -11.87% | $915.05M | 0.35% |
CGSD | -11.66% | $1.29B | 0.25% |
BILS | -10.71% | $3.93B | 0.1356% |
GBIL | -10.60% | $6.18B | 0.12% |
SHV | -10.30% | $20.36B | 0.15% |
ICSH | -10.15% | $6.15B | 0.08% |
CARY | -10.10% | $347.36M | 0.8% |
KMLM | -9.81% | $191.24M | 0.9% |
TBLL | -9.78% | $2.24B | 0.08% |
FPEI | -9.42% | $1.59B | 0.85% |
GSY | -9.34% | $2.78B | 0.22% |
XLU | -9.29% | $18.49B | 0.09% |
EPI | -9.27% | $3.33B | 0.85% |
FIXD | -9.12% | $3.40B | 0.65% |
SMIN | -9.07% | $920.99M | 0.75% |
VPU | -9.01% | $7.08B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MAGS | <0.01% | $2.37B | 0.29% |
EFAV | <0.01% | $5.56B | 0.2% |
PREF | -0.01% | $1.20B | 0.55% |
FXO | 0.01% | $2.09B | 0.62% |
EMHC | 0.02% | $186.35M | 0.23% |
XRT | -0.02% | $327.28M | 0.35% |
EIS | -0.03% | $264.41M | 0.59% |
PBJ | 0.03% | $101.23M | 0.62% |
FLJP | 0.04% | $2.15B | 0.09% |
SHLD | -0.05% | $2.47B | 0.5% |
VNQI | 0.06% | $3.33B | 0.12% |
URA | -0.06% | $3.56B | 0.69% |
FXH | -0.07% | $911.90M | 0.62% |
GHYB | 0.07% | $91.98M | 0.15% |
DFNM | 0.08% | $1.56B | 0.17% |
CLIP | 0.08% | $1.50B | 0.07% |
IYC | -0.09% | $1.48B | 0.39% |
TIP | -0.09% | $13.72B | 0.18% |
HYLB | -0.11% | $3.86B | 0.05% |
SPSK | 0.11% | $315.36M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UVE | -48.56% | $744.15M | +45.16% | 2.42% |
HCI | -41.74% | $1.80B | +65.46% | 1.02% |
ACIC | -30.64% | $504.33M | +0.77% | 0.00% |
RNR | -29.66% | $11.89B | +12.09% | 0.80% |
HRTG | -29.25% | $713.16M | +204.37% | 0.00% |
EG | -28.25% | $14.23B | -8.96% | 2.37% |
CB | -20.66% | $114.92B | +10.53% | 1.60% |
ACGL | -20.13% | $34.10B | -1.62% | 0.00% |
CON | -20.00% | $2.75B | -8.72% | 0.58% |
RLI | -19.82% | $6.70B | +7.02% | 1.21% |
IMRN | -19.45% | $10.12M | -20.28% | 0.00% |
AIZ | -18.14% | $10.05B | +19.71% | 1.56% |
DUK | -17.51% | $90.83B | +14.17% | 3.57% |
ALL | -17.28% | $52.68B | +26.64% | 1.92% |
AWK | -17.01% | $27.58B | +9.39% | 2.19% |
PLMR | -15.97% | $4.30B | +100.84% | 0.00% |
IAG | -14.89% | $4.39B | +110.77% | 0.00% |
PGR | -14.83% | $157.02B | +31.35% | 1.83% |
HALO | -14.82% | $6.65B | +9.05% | 0.00% |
CCEC | -14.31% | $1.02B | +3.91% | 2.86% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BZUN | -<0.01% | $150.94M | +19.92% | 0.00% |
HUM | <0.01% | $28.39B | -34.46% | 1.50% |
BYND | -<0.01% | $241.65M | -52.48% | 0.00% |
CHTR | <0.01% | $53.70B | +40.71% | 0.00% |
VICR | -0.01% | $1.97B | +28.42% | 0.00% |
CODX | -0.02% | $9.30M | -82.65% | 0.00% |
NVAX | 0.03% | $1.12B | -51.81% | 0.00% |
MLI | 0.03% | $8.22B | +35.31% | 1.20% |
PAYX | 0.04% | $55.19B | +25.60% | 2.62% |
BTG | 0.04% | $4.98B | +44.44% | 3.24% |
AGL | -0.04% | $890.00M | -68.84% | 0.00% |
RY | -0.04% | $180.16B | +22.91% | 3.23% |
CSAN | -0.05% | $2.76B | -37.46% | 0.00% |
ACVA | -0.05% | $2.63B | -13.00% | 0.00% |
PDD | -0.05% | $139.68B | -32.49% | 0.00% |
EDU | 0.05% | $7.61B | -37.52% | 0.00% |
EVRI | -0.05% | $1.23B | +78.21% | 0.00% |
ALXO | -0.05% | $27.38M | -93.63% | 0.00% |
CMPR | -0.05% | $1.07B | -48.11% | 0.00% |
INNV | 0.05% | $477.95M | -30.32% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CNYA | 29.17% | $217.85M | 0.6% |
ASHR | 26.59% | $1.94B | 0.65% |
LIT | 23.87% | $821.24M | 0.75% |
REMX | 23.10% | $282.34M | 0.58% |
GXC | 20.12% | $435.47M | 0.59% |
CQQQ | 19.06% | $1.02B | 0.65% |
KBA | 18.70% | $172.94M | 0.56% |
FLCH | 17.73% | $191.58M | 0.19% |
MCHI | 17.03% | $6.49B | 0.59% |
CXSE | 16.89% | $428.59M | 0.32% |
EWX | 16.57% | $701.18M | 0.65% |
USL | 16.36% | $41.48M | 0.85% |
BATT | 15.23% | $58.57M | 0.59% |
CHIQ | 14.97% | $237.62M | 0.65% |
DBE | 14.83% | $49.77M | 0.77% |
BNO | 14.65% | $90.75M | 1% |
OILK | 14.61% | $71.58M | 0.69% |
DBO | 14.32% | $225.49M | 0.77% |
JPEM | 13.82% | $340.68M | 0.44% |
USO | 13.58% | $982.22M | 0.6% |
Yahoo
CAMBRIDGE, Mass., June 13, 2025--Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 309,700 shares of its common stock to 11 newly hired employees, consisting of inducement stock options to purchase an aggregate of 17
Finnhub
Scholar Rock Holding Corp: * SCHOLAR ROCK REPORTS NEW EMPLOYEE INDUCEMENT GRANTS UNDERNASDAQLISTING RULE 5635Source text:Further company coverage: ...
Finnhub
Presenter SpeechUnknown Executive Many years of opportunity with our organic pipeline to grow our business. But of course, we'll always be thoughtful I think 1 of the things of Vikas and I, and we...
Yahoo
In the last week, the United States market has been flat, but it is up 11% over the past year with earnings expected to grow by 14% per annum over the next few years. In this context, identifying high growth tech stocks involves looking for companies that not only demonstrate strong innovation and scalability but also have solid financial health to capitalize on these favorable market conditions.
Yahoo
CAMBRIDGE, Mass., June 05, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that David L. Hallal, Chief Executive Officer, and members of management will participate in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11 at 9:20 a.m. ET in Miami, Flor
Yahoo
CAMBRIDGE, Mass., June 02, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that Rebecca McLeod has been appointed to the newly created role of Chief Brand Officer and U.S. General Manager. In this role, she will be responsible for leading the anticipated U.S. commercial launch of apitegromab for p
Current Value
$32.511 Year Return
Current Value
$32.511 Year Return